Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Herpes simplex Infection

  Free Subscription

Articles published in J Virol

Retrieve available abstracts of 72 articles:
HTML format

Single Articles

    April 2023
  1. CUDDY SR, Cliffe AR
    The Intersection of Innate Immune Pathways with the Latent Herpes Simplex Virus Genome.
    J Virol. 2023 Apr 27:e0135222. doi: 10.1128/jvi.01352.
    PubMed     Abstract available

  2. SANTOS VC, Ostler JB, Harrison KS, Jones C, et al
    Slug, a Stress-Induced Transcription Factor, Stimulates Herpes Simplex Virus 1 Replication and Transactivates a cis-Regulatory Module within the VP16 Promoter.
    J Virol. 2023 Apr 6:e0007323. doi: 10.1128/jvi.00073.
    PubMed     Abstract available

    February 2023
  3. WANG J, Qin X, Huang Y, Zhang G, et al
    Sirt1 Negatively Regulates Cellular Antiviral Responses by Preventing the Cytoplasmic Translocation of Interferon-Inducible Protein 16 in Human Cells.
    J Virol. 2023;97:e0197522.
    PubMed     Abstract available

  4. GRAMS TR, Edwards TG, Bloom DC
    HSV-1 LAT Promoter Deletion Viruses Exhibit Strain-Specific and LAT-Dependent Epigenetic Regulation of Latent Viral Genomes in Human Neurons.
    J Virol. 2023;97:e0193522.
    PubMed     Abstract available

    January 2023
  5. BRUNIALTI M, Hofler T, Nascimento M, Trimpert J, et al
    Suicidal Phenotype of Proofreading-Deficient Herpes Simplex Virus 1 Polymerase Mutants.
    J Virol. 2023 Jan 4:e0135922. doi: 10.1128/jvi.01359.
    PubMed     Abstract available

    December 2022
  6. NAZLI A, Chow R, Zahoor MA, Workenhe ST, et al
    LAMP3/CD63 Expression in Early and Late Endosomes in Human Vaginal Epithelial Cells Is Associated with Enhancement of HSV-2 Infection.
    J Virol. 2022;96:e0155322.
    PubMed     Abstract available

  7. XU H, Wang J, Deng Y, Hou F, et al
    Two-Color CRISPR Imaging Reveals Dynamics of Herpes Simplex Virus 1 Replication Compartments and Virus-Host Interactions.
    J Virol. 2022 Dec 1:e0092022. doi: 10.1128/jvi.00920.
    PubMed     Abstract available

    November 2022
  8. TAKESHIMA K, Maruzuru Y, Koyanagi N, Kato A, et al
    Redundant and Specific Roles of A-Type Lamins and Lamin B Receptor in Herpes Simplex Virus 1 Infection.
    J Virol. 2022 Nov 30:e0142922. doi: 10.1128/jvi.01429.
    PubMed     Abstract available

  9. JAGGI U, Matundan HH, Lee DH, Ghiasi H, et al
    Blocking Autophagy in M1 Macrophages Enhances Virus Replication and Eye Disease in Ocularly Infected Transgenic Mice.
    J Virol. 2022;96:e0140122.
    PubMed     Abstract available

    October 2022
  10. MOHNKE J, Stark I, Fischer M, Fischer PM, et al
    pUL36 Deubiquitinase Activity Augments Both the Initiation and the Progression of Lytic Herpes Simplex Virus Infection in IFN-Primed Cells.
    J Virol. 2022 Oct 31:e0096322. doi: 10.1128/jvi.00963.
    PubMed     Abstract available

  11. DUNN LEM, Birkenheuer CH, Dufour R, Baines JD, et al
    Immediate Early Proteins of Herpes Simplex Virus Transiently Repress Viral Transcription before Subsequent Activation.
    J Virol. 2022 Oct 27:e0141622. doi: 10.1128/jvi.01416.
    PubMed     Abstract available

    August 2022
  12. ZACHOS G, Koffa M, Preston CM, Clements JB, et al
    Retraction for Zachos et al., "Herpes Simplex Virus Type 1 Blocks the Apoptotic Host Cell Defense Mechanisms That Target Bcl-2 and Manipulates Activation of p38 Mitogen-Activated Protein Kinase to Improve Viral Replication".
    J Virol. 2022 Aug 30:e0104422. doi: 10.1128/jvi.01044.

  13. SIVASUBRAMANIAN MK, Monteiro R, Harrison KS, Plakkot B, et al
    Herpes Simplex Virus Type 1 Preferentially Enhances Neuro-Inflammation and Senescence in Brainstem of Female Mice.
    J Virol. 2022 Aug 17:e0108122. doi: 10.1128/jvi.01081.
    PubMed     Abstract available

  14. MOCKEL M, De La Cruz NC, Rubsam M, Wirtz L, et al
    Herpes Simplex Virus 1 Can Bypass Impaired Epidermal Barriers upon Ex Vivo Infection of Skin from Atopic Dermatitis Patients.
    J Virol. 2022 Aug 15:e0086422. doi: 10.1128/jvi.00864.
    PubMed     Abstract available

  15. RANA M, Setia M, Suvas PK, Chakraborty A, et al
    Diphenyleneiodonium Treatment Inhibits the Development of Severe Herpes Stromal Keratitis Lesions.
    J Virol. 2022 Aug 10:e0101422. doi: 10.1128/jvi.01014.
    PubMed     Abstract available

  16. GIANOPULOS KA, Komala Sari T, Weed DJ, Pritchard SM, et al
    Conformational Changes in Herpes Simplex Virus Glycoprotein C.
    J Virol. 2022 Aug 1:e0016322. doi: 10.1128/jvi.00163.
    PubMed     Abstract available

    July 2022
  17. BERBER E, Rouse BT
    Controlling Herpes Simplex Virus-Induced Immunoinflammatory Lesions Using Metabolic Therapy: a Comparison of 2-Deoxy-d-Glucose with Metformin.
    J Virol. 2022 Jul 11:e0068822. doi: 10.1128/jvi.00688.
    PubMed     Abstract available

    June 2022
  18. WISE EL, Samolej J, Elliott G
    Herpes Simplex Virus 1 Expressing GFP-Tagged Virion Host Shutoff (vhs) Protein Uncouples the Activities of RNA Degradation and Differential Nuclear Retention of the Virus Transcriptome.
    J Virol. 2022 Jun 27:e0192621. doi: 10.1128/jvi.01926.
    PubMed     Abstract available

    May 2022
  19. TESSEMA MB, Farrukee R, Andoniou CE, Degli-Esposti MA, et al
    Mouse Mx1 Inhibits Herpes Simplex Virus Type 1 Genomic Replication and Late Gene Expression In Vitro and Prevents Lesion Formation in the Mouse Zosteriform Model.
    J Virol. 2022 May 31:e0041922. doi: 10.1128/jvi.00419.
    PubMed     Abstract available

  20. DOCHNAL S, Merchant HY, Schinlever AR, Babnis A, et al
    DLK-Dependent Biphasic Reactivation of Herpes Simplex Virus Latency Established in the Absence of Antivirals.
    J Virol. 2022 May 24:e0050822. doi: 10.1128/jvi.00508.
    PubMed     Abstract available

  21. WHITFORD AL, Clinton CA, Kennedy EBL, Dochnal SA, et al
    Ex Vivo Herpes Simplex Virus Reactivation Involves a Dual Leucine Zipper Kinase-Dependent Wave of Lytic Gene Expression That Is Independent of Histone Demethylase Activity and Viral Genome Synthesis.
    J Virol. 2022 May 23:e0047522. doi: 10.1128/jvi.00475.
    PubMed     Abstract available

  22. CHEN S, Deng Y, Chen H, Lin Y, et al
    Neuronal miR-138 Represses HSV-2 Lytic Infection by Regulating Viral and Host Genes with Mechanistic Differences from HSV-1.
    J Virol. 2022;96:e0034922.
    PubMed     Abstract available

    April 2022
  23. MAEDA F, Kato A, Takeshima K, Shibazaki M, et al
    Role of the Orphan Transporter SLC35E1 in the Nuclear Egress of Herpes Simplex Virus 1.
    J Virol. 2022 Apr 27:e0030622. doi: 10.1128/jvi.00306.
    PubMed     Abstract available

    March 2022
  24. MA Y, Li J, Dong H, Yang Z, et al
    PML Body Component Sp100A Restricts Wild-Type Herpes Simplex Virus 1 Infection.
    J Virol. 2022 Mar 30:e0027922. doi: 10.1128/jvi.00279.
    PubMed     Abstract available

  25. KATZILIERIS-PETRAS G, Lai X, Rashidi AS, Verjans GMGM, et al
    Microglia Activate Early Antiviral Responses upon Herpes Simplex Virus 1 Entry into the Brain to Counteract Development of Encephalitis-Like Disease in Mice.
    J Virol. 2022;96:e0131121.
    PubMed     Abstract available

  26. DHANUSHKODI NR, Prakash S, Srivastava R, Coulon PA, et al
    Antiviral CD19(+)CD27(+) Memory B Cells Are Associated with Protection from Recurrent Asymptomatic Ocular Herpesvirus Infection.
    J Virol. 2022;96:e0205721.
    PubMed     Abstract available

  27. TORMANEN K, Matundan HH, Wang S, Jaggi U, et al
    Small Noncoding RNA (sncRNA1) within the Latency-Associated Transcript Modulates Herpes Simplex Virus 1 Virulence and the Host Immune Response during Acute but Not Latent Infection.
    J Virol. 2022 Mar 7:e0005422. doi: 10.1128/jvi.00054.
    PubMed     Abstract available

    February 2022
  28. TORMANEN K, Wang S, Matundan HH, Yu J, et al
    Herpes Simplex Virus 1 Small Noncoding RNAs 1 and 2 Activate the Herpesvirus Entry Mediator Promoter.
    J Virol. 2022;96:e0198521.
    PubMed     Abstract available

    January 2022
  29. GMYREK GB, Predki P, Gershburg E, Carr DJJ, et al
    Noncognate Signals Drive Enhanced Effector CD8(+) T Cell Responses through an IFNAR1-Dependent Pathway after Infection with the Prototypic Vaccine, 0DeltaNLS, against Herpes Simplex Virus 1.
    J Virol. 2022 Jan 19:JVI0172421. doi: 10.1128/JVI.01724.
    PubMed     Abstract available

  30. BIRKENHEUER CH, Dunn L, Dufour R, Baines JD, et al
    The ICP22 protein of Herpes Simplex Virus 1 decreases RNA Polymerase Processivity.
    J Virol. 2022 Jan 12:jvi0219121. doi: 10.1128/jvi.02191.
    PubMed     Abstract available

    December 2021
  31. VAN GENT M, Chiang JJ, Muppala S, Chiang C, et al
    The US3 kinase of Herpes Simplex virus phosphorylates the RNA sensor RIG-I to suppress innate immunity.
    J Virol. 2021 Dec 22:JVI0151021. doi: 10.1128/JVI.01510.
    PubMed     Abstract available

  32. WIRTZ L, De La Cruz NC, Mockel M, Knebel-Morsdorf D, et al
    Susceptibility of human and murine dermal fibroblasts to Herpes simplex Virus 1 in the absence and presence of extracellular matrix.
    J Virol. 2021 Dec 15:JVI0206821. doi: 10.1128/JVI.02068.
    PubMed     Abstract available

  33. HAYES CK, Giraldo D, Wilcox DR, Longnecker R, et al
    The Astrocyte Type I Interferon Response is Essential for Protection Against Herpes Simplex Encephalitis.
    J Virol. 2021 Dec 8:JVI0178321. doi: 10.1128/JVI.01783.
    PubMed     Abstract available

    November 2021
  34. ROLLER RJ, Hassman T, Haugo-Crooks A
    Cell Culture Evolution of a Herpes Simplex Virus 1 (HSV-1)/Varicella-Zoster Virus (VZV) UL34/ORF24 Chimeric Virus Reveals Novel Functions for HSV Genes in Capsid Nuclear Egress.
    J Virol. 2021;95:e0095721.
    PubMed     Abstract available

  35. ARII J, Takeshima K, Maruzuru Y, Koyanagi N, et al
    Role of the arginine cluster in the disordered domain of Herpes Simplex Virus 1 UL34 for the recruitment of ESCRT-III for viral primary envelopment.
    J Virol. 2021 Nov 3:JVI0170421. doi: 10.1128/JVI.01704.
    PubMed     Abstract available

    September 2021
  36. MATUNDAN HH, Wang S, Jaggi U, Yu J, et al
    Suppression of CD80 Expression by ICP22 Affects Herpes Simplex Virus Type 1 Replication and CD8(+)IFN-gamma(+) Infiltrates in the Eyes of Infected Mice but Not Latency Reactivation.
    J Virol. 2021;95:e0103621.
    PubMed     Abstract available

    August 2021
  37. FAN Q, Longnecker R, Connolly SA
    Herpes simplex virus glycoprotein B (gB) mutations define structural sites in domain I, the membrane proximal region, and the cytodomain that regulate entry.
    J Virol. 2021 Aug 25:JVI0105021. doi: 10.1128/JVI.01050.
    PubMed     Abstract available

  38. DE LA CRUZ NC, Mockel M, Wirtz L, Sunaoglu K, et al
    Ex vivo infection of human skin with herpes simplex virus 1 reveals mechanical wounds as insufficient entry portals via the skin surface.
    J Virol. 2021 Aug 11:JVI0133821. doi: 10.1128/JVI.01338.
    PubMed     Abstract available

  39. VU A, White S, Cassmann T, Roller RJ, et al
    Herpes Simplex Virus 1 UL34 Mutants That Affect Membrane Budding Regulation and Nuclear Lamina Disruption.
    J Virol. 2021;95:e0087321.
    PubMed     Abstract available

    April 2021
  40. MEIER AF, Tobler K, Michaelsen K, Vogt B, et al
    Herpes Simplex Virus Type 1 Co-Infection Modifies Adeno-Associated Virus Genome End Recombination.
    J Virol. 2021 Apr 14. pii: JVI.00486-21. doi: 10.1128/JVI.00486.
    PubMed     Abstract available

  41. IKEDA H, Uchida H, Okubo Y, Shibata T, et al
    Antibody Screening System Using a Herpes Simplex Virus (HSV)-Based Probe To Identify a Novel Target for Receptor-Retargeted Oncolytic HSVs.
    J Virol. 2021;95.
    PubMed     Abstract available

    February 2021
  42. ARACHCHIGE SP, Henke W, Kalamvoki M, Stephens EB, et al
    Structural Domains of the Herpes Simplex Type 1 gD Protein that Restrict HIV-1 Particle Infectivity.
    J Virol. 2021 Feb 3. pii: JVI.02355-20. doi: 10.1128/JVI.02355.
    PubMed     Abstract available

    January 2021
  43. ZHENG W, Klammer AM, Naciri JN, Yeung J, et al
    Correction for Zheng et al., "Patterns of Herpes Simplex Virus 1 Infection in Neural Progenitor Cells".
    J Virol. 2021;95.

  44. SUMBRIA D, Berber E, Rouse BT
    Supplementing the Diet with Sodium Propionate Suppresses the Severity of Viral Immuno-inflammatory Lesions.
    J Virol. 2021;95.
    PubMed     Abstract available

  45. OSTLER JB, Thunuguntla P, Hendrickson BY, Jones C, et al
    Transactivation of Herpes Simplex Virus 1 (HSV-1) Infected Cell Protein 4 Enhancer by Glucocorticoid Receptor and Stress-Induced Transcription Factors Requires Overlapping Kruppel-Like Transcription Factor 4/Sp1 Binding Sites.
    J Virol. 2021;95.
    PubMed     Abstract available

    December 2020
  46. DOGRAMMATZIS C, Saleh S, Deighan C, Kalamvoki M, et al
    Diverse populations of extracellular vesicles with opposite functions during herpes simplex virus 1 infection.
    J Virol. 2020 Dec 23. pii: JVI.02357-20. doi: 10.1128/JVI.02357.
    PubMed     Abstract available

  47. MARUZURU Y, Koyanagi N, Kato A, Kawaguchi Y, et al
    Role of the DNA Binding Activity of Herpes Simplex Virus 1 VP22 in Evading AIM2-Dependent Inflammasome Activation Induced by the Virus.
    J Virol. 2020 Dec 9. pii: JVI.02172-20. doi: 10.1128/JVI.02172.
    PubMed     Abstract available

  48. ABRAHAMSON EE, Zheng W, Muralidaran V, Ikonomovic MD, et al
    Modeling Abeta42 Accumulation in Response to Herpes Simplex Virus 1 Infection: 2D or 3D?
    J Virol. 2020 Dec 2. pii: JVI.02219-20. doi: 10.1128/JVI.02219.
    PubMed     Abstract available

    November 2020
  49. EL BILALI N, Khadivjam B, Bonneil E, Thibault P, et al
    Proteomics of Herpes Simplex Virus Type 1 Nuclear Capsids.
    J Virol. 2020 Nov 25. pii: JVI.01842-19. doi: 10.1128/JVI.01842.
    PubMed     Abstract available

  50. DE LA CRUZ N, Knebel-Morsdorf D
    Endocytic Internalization of Herpes Simplex Virus 1 in Human Keratinocytes at Low Temperature.
    J Virol. 2020 Nov 25. pii: JVI.02195-20. doi: 10.1128/JVI.02195.
    PubMed     Abstract available

  51. BARROZO ER, Nakayama S, Singh P, Neumann DM, et al
    Herpes Simplex Virus 1 microRNA miR-H8 is Dispensable for Latency and Reactivation in Vivo.
    J Virol. 2020 Nov 18. pii: JVI.02179-20. doi: 10.1128/JVI.02179.
    PubMed     Abstract available

  52. UCHE IK, Fowlkes N, Vu L, Watanabe T, et al
    The Novel Oncolytic Herpes Simplex Virus Type-1 (HSV-1) VC2 Promotes Long-lasting, Systemic Anti-melanoma Tumor Immune Responses and Increased Survival in an Immunocompetent B16F10-derived Mouse Melanoma Model.
    J Virol. 2020 Nov 11. pii: JVI.01359-20. doi: 10.1128/JVI.01359.
    PubMed     Abstract available

  53. WATANABE M, Arii J, Takeshima K, Fukui A, et al
    Prohibitin-1 Contributes to the Cell-to-Cell Transmission of Herpes Simplex Virus 1.
    J Virol. 2020 Nov 11. pii: JVI.01413-20. doi: 10.1128/JVI.01413.
    PubMed     Abstract available

  54. FRIEDEL CC, Whisnant AW, Djakovic L, Rutkowski AJ, et al
    Dissecting Herpes Simplex Virus 1-Induced Host Shutoff at the RNA Level.
    J Virol. 2020 Nov 4. pii: JVI.01399-20. doi: 10.1128/JVI.01399.
    PubMed     Abstract available

    October 2020
  55. KIM DJ, Khoury-Hanold W, Jain PC, Klein J, et al
    RUNX Binding Sites Are Enriched in Herpesvirus Genomes, and RUNX1 Overexpression Leads to Herpes Simplex Virus 1 Suppression.
    J Virol. 2020;94.
    PubMed     Abstract available

  56. BORUCHOWICZ H, Hawkins J, Cruz-Palomar K, Lippe R, et al
    The XPO6 Exportin Mediates Herpes Simplex Virus 1 gM Nuclear Release Late in Infection.
    J Virol. 2020;94.
    PubMed     Abstract available

  57. ZHAO J, Zhu L, Wijesekera N, Jones C, et al
    Specific Akt Family Members Impair Stress-Mediated Transactivation of Viral Promoters and Enhance Neuronal Differentiation: Important Functions for Maintaining Latency.
    J Virol. 2020;94.
    PubMed     Abstract available

  58. BAGRI P, Ghasemi R, McGrath JJC, Thayaparan D, et al
    Estradiol enhances anti-viral CD4(+) tissue-resident memory T cell responses following mucosal herpes simplex virus 2 vaccination through an IL-17-mediated pathway.
    J Virol. 2020 Oct 7. pii: JVI.01206-20. doi: 10.1128/JVI.01206.
    PubMed     Abstract available

  59. TEBALDI G, Pritchard SM, Nicola AV
    Herpes simplex virus entry by a non-conventional endocytic pathway.
    J Virol. 2020 Oct 7. pii: JVI.01910-20. doi: 10.1128/JVI.01910.
    PubMed     Abstract available

  60. STINN T, Kuntz S, Varon D, Huang ML, et al
    Subclinical genital herpes shedding in HIV/HSV-2 co-infected women during antiretroviral therapy (ART) is associated with an increase in HIV tissue reservoirs and potentially promotes HIV evolution.
    J Virol. 2020 Oct 7. pii: JVI.01606-20. doi: 10.1128/JVI.01606.
    PubMed     Abstract available

    September 2020
  61. ARII J, Fukui A, Shimanaka Y, Kono N, et al
    Role of phosphatidyl-ethanolamine biosynthesis in herpes simplex virus 1 infected cells on progeny virus morphogenesis in the cytoplasm and on viral pathogenicity in vivo.
    J Virol. 2020 Sep 30. pii: JVI.01572-20. doi: 10.1128/JVI.01572.
    PubMed     Abstract available

  62. GMYREK GB, Filiberti A, Montgomery M, Chitrakar A, et al
    HSV-1 0DeltaNLS Live-Attenuated Vaccine Protects Against Ocular HSV-1 Infection in the Absence of Neutralizing Antibody in HSV-1 gB T Cell Receptor-Specific Transgenic Mice.
    J Virol. 2020 Sep 30. pii: JVI.01000-20. doi: 10.1128/JVI.01000.
    PubMed     Abstract available

  63. HARANCHER MR, Packard JE, Cowan SP, DeLuca NA, et al
    Antiviral Properties of the LSD1 Inhibitor SP-2509.
    J Virol. 2020;94.
    PubMed     Abstract available

    August 2020
  64. SHIBAZAKI M, Kato A, Takeshima K, Ito J, et al
    Phosphoregulation of a Conserved Herpesvirus Tegument Protein by a Virally Encoded Protein Kinase in Viral Pathogenicity and Potential Linkage between Its Evolution and Viral Phylogeny.
    J Virol. 2020;94.
    PubMed     Abstract available

    July 2020
  65. TORMANEN K, Wang S, Jaggi U, Ghiasi H, et al
    Restoring Herpesvirus Entry Mediator (HVEM) Immune Function in HVEM(-/-) Mice Rescues Herpes Simplex Virus 1 Latency and Reactivation Independently of Binding to Glycoprotein D.
    J Virol. 2020;94.
    PubMed     Abstract available

  66. ZHENG W, Klammer AM, Naciri JN, Yeung J, et al
    Patterns of Herpes Simplex Virus 1 Infection in Neural Progenitor Cells.
    J Virol. 2020;94.
    PubMed     Abstract available

    June 2020
  67. SURYAWANSHI RK, Koujah L, Patil CD, Ames JM, et al
    Bacterial Pigment Prodigiosin Demonstrates a Unique Antiherpesvirus Activity That Is Mediated through Inhibition of Prosurvival Signal Transducers.
    J Virol. 2020;94.
    PubMed     Abstract available

  68. ZHOU X, Wang L, Zou W, Chen X, et al
    hnRNPA2B1 Associated with Recruitment of RNA into Exosomes Plays a Key Role in Herpes Simplex Virus 1 Release from Infected Cells.
    J Virol. 2020;94.
    PubMed     Abstract available

  69. JAN FADA B, Kaadi E, Samrat SK, Zheng Y, et al
    Effect of SUMO-SIM Interaction on the ICP0-Mediated Degradation of PML Isoform II and Its Associated Proteins in Herpes Simplex Virus 1 Infection.
    J Virol. 2020;94.
    PubMed     Abstract available

    April 2020
  70. DHANUSHKODI NR, Srivastava R, Prakash S, Roy S, et al
    High Frequency of Gamma Interferon-Producing PLZF(lo)RORgammat(lo) Invariant Natural Killer 1 Cells Infiltrating Herpes Simplex Virus 1-Infected Corneas Is Associated with Asymptomatic Ocular Herpesvirus Infection.
    J Virol. 2020;94.
    PubMed     Abstract available

  71. POWELL-DOHERTY RD, Abbott ARN, Nelson LA, Bertke AS, et al
    Amyloid-beta and p-Tau Anti-Threat Response to Herpes Simplex Virus 1 Infection in Primary Adult Murine Hippocampal Neurons.
    J Virol. 2020;94.
    PubMed     Abstract available

    March 2020
  72. DONG X, Zhou J, Qin HB, Xin B, et al
    Anterograde Viral Tracer Herpes Simplex Virus 1 Strain H129 Transports Primarily as Capsids in Cortical Neuron Axons.
    J Virol. 2020;94.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Herpes simplex Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.